NewsRx

Search our medical news database

Genetics and Cervical Cancer

Study confirms HPV genotypes responsible for majority of cervical cancers worldwide

Published in Vaccine Weekly, November 3rd, 2010

Eight human papillomavirus (HPV) types (16, 18, 45, 33, 31, 52, 58, and 35) are responsible for over 90% of all cervical cancer cases worldwide, and should be the target of the next generation vaccines, according to the largest study of HPV genotypes to date, published Online First in The Lancet Oncology. HPV 16, 18, and 45 are the most common types and occur at a much younger age than other high-risk HPV genotypes. As such, these three HPV types should be the focus of future type-specific HPV screening.

Cervical cancer is the second most common cancer among women worldwide, and is predicted to result in nearly 328 000 deaths in 2010. The disease is caused by high-risk...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook